Date: Tuesday 29th March 2022
Time: 12:00-13:00 BST
Speakers: Amanda Darekar (Pfizer), Joanne Mann (Veramed) and Holly Tovey (Institute for Cancer Research).
Who is this event intended for? Statisticians at all levels.
What is the benefit of attending? Learn about different career trajectories from Statisticians across the healthcare industry and expand your view on the role of 'Statistician'.
Registration for this webinar is free, and is open to Members of PSI only.
To register for this event, please click here.
Climbing the traditional Career Ladder has long been associated with career progression with the ultimate goal of moving into management. Statistics as a field has grown in prominence, especially in the last few years and with that growth we re-examine whether the traditional Career Ladder is still relevant.
Hear from others in the PSI Community who look to forge their own path in the industry as a Statistician. They will give their own personal views and experiences on creating your own career path.
|
Speaker |
Biography |
|
|
Joanne is a Principal level Statistician working at Veramed. She has over 25 years experience in the Pharmaceutical Industry, working as a project statistician and in project statistical oversight for Contract Research Organisations (including Covance, PharmaNet and inVentiv Health) and more recently for Pharma companies such as Eli Lilly. She has experience within both early and late phase clinical trials, and in a wide range of therapeutic areas including oncology.
|
|
|
Amanda has nearly 25 years’ experience in the industry. She started her career at Quintiles (now IQVIA) supporting a wide range of clients and projects, followed by a stint at Pharmacia, a mid-size pharmaceutical company, moving to Pfizer after its acquisition of Pharmacia in 2003. Since then, Amanda has supported a wide range of projects spanning many therapeutic areas and phases, initially working on early development studies in neurology/pain and urology, and in 2007 Amanda undertook a year-long secondment to Pfizer India to manage a statistics group in Mumbai. Once back in the UK, she returned to supporting a variety of projects within urology and cardiovascular/metabolic therapeutic areas. Amanda is currently statistical program lead for two projects within the Internal Medicine Statistics Cluster.
|
|
|
Holly Tovey is a senior statistician and PhD student in the Clinical Trials and Statistics Unit at the Institute of Cancer Research. The aim of her thesis is the identification of biomarkers to predict response for emerging therapeutic agents for triple negative breast cancer. Her main areas of interest are machine learning and effective incorporation of biomarkers in clinical trials.
|
